Post-Conference Perspectives: Updates in Colorectal Cancer: Highlights from ASCO GI 2023 and Beyond

home / news-network / updates-in-colorectal-cancer-highlights-from-asco-gi-2023-and-beyond

Tanios S. Bekaii-Saab, MD, FACP describes the current colorectal cancer (CRC) treatment landscape, shares relevant updates from the American Society for Clinical Oncology’s Gastrointestinal Cancers Symposium 2023, and discusses his hopes for the future of the field.

An Introduction to Biomarker Testing in Metastatic Colorectal Cancer

EP. 1: An Introduction to Biomarker Testing in Metastatic Colorectal Cancer

February 16th 2023

Tanios S. Bekaii-Saab, MD, FACP introduces the metastatic colorectal cancer (mCRC) treatment landscape and the emphasizes importance of biomarker testing in patients with mCRC.

Clinical Trial Review: MOUNTAINEER

EP. 2: Clinical Trial Review: MOUNTAINEER

February 16th 2023

An expert in gastrointestinal cancers reviews outcomes from the MOUNTAINEER clinical trial, focusing on concordance analysis data for HER2 testing as well as the efficacy of tucatinib and trastuzumab.

MOUNTAINEER-03 Clinical Trial Study Design and Implications

EP. 3: MOUNTAINEER-03 Clinical Trial Study Design and Implications

February 23rd 2023

Clinical insights regarding the design, patient population, and overall aims of the ongoing phase 3 clinical trial MOUNTAINEER-03.

Emerging Treatment Options for Patients with HER2+ Metastatic Colorectal Cancer

EP. 4: Emerging Treatment Options for Patients with HER2+ Metastatic Colorectal Cancer

February 23rd 2023

Discussion centered around emerging treatment options for patients with HER2+ mCRC, including trastuzumab deruxtucan.

The Future of the Metastatic Colorectal Cancer Treatment Landscape

EP. 5: The Future of the Metastatic Colorectal Cancer Treatment Landscape

March 2nd 2023

Dr Tanios S. Bekaii-Saab closes the discussion with key unmet needs in the mCRC treatment landscape.